Experience in using the new neuroleptic, azabutyrone, in clinical anesthesiology
Zakusov, V.V.; Ostrovskiĭ, V.I.; Raevskiĭ, K.S.; Bulanova, L.F.
Anesteziologiia i Reanimatologiia 5: 35-38
1977
ISSN/ISBN: 0201-7563 PMID: 335920 Document Number: 113889
Document emailed within 1 workday
Related Documents
Bonhour, A.; Borel, R.O. 1971: Clinical experience with a new neuroleptic (R. 6238) Prensa Medica Argentina 58(24): 1265-1266Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Camu, F. 1989: Experience of Anexate in anesthesiology Acta Anaesthesiologica Belgica 40(1): 17-22
Vanevskiĭ, V.L.; Kargapolov, L.N. 1970: Experience in the use of a new Soviet myorelaxant, dioxonium, in anesthesiology Vestnik Khirurgii Imeni I. I. Grekova 104(6): 74-77
Curelaru, I.; Curelaru, I. 1973: Physico-mathematical basis of anesthesiology. II. Fundamental notions of mechanics applicable in anesthesiology Chirurgia 22(6): 553-563
Curelaru, I.; Curelaru, I. 1973: Physico-mathematical basis of anesthesiology. I. Measurements, units and physical symbols used in anesthesiology Chirurgia 22(5): 469-478
White, P.F.; Watcha, M.F. 1993: The practice of anesthesiology and the package insert: decision-making regarding drug use in anesthesiology Anesthesia and Analgesia 76(5): 928-930
Tanghe, A.; Vereecken, J.L. 1970: Experience with a new neuroleptic, benperidol L'Encephale 59(5): 479-485
Desai, N.D.; Mundra, V.K.; Gore, Y.S.; Diwan, P.J.; Jaydeokar, S.S.; Jain, V.; Sutharsan, R.; Agarwal, A.; Moulick, N.D.; Manocha, S.M. 1998: Neuroleptic malignant syndrome: an experience of four cases Journal of the Association of Physicians of India 46(7): 653-654
Pochatov, I.M.; Raevskiĭ, K.S. 1977: Effect of azabutyrone and its analogs on catecholamine metabolism in the brains of rats Farmakologiia i Toksikologiia 40(1): 5-8
Maling, T.J.; MacDonald, A.D.; Davis, M.; Hawkins, T. 1988: Neuroleptic malignant syndrome: a review of the Wellington experience New Zealand Medical Journal 101(844): 193-195
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
García-Pedrajas, F.; Monedero, P. 1992: Benzodiazepines in anesthesiology. Clinical applications (II) Revista Espanola de Anestesiologia y Reanimacion 39(2): 126-131
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Vila Sánchez, M.; de Andrés Ibáñez, J.A. 1987: Morbidity and mortality in the clinical practice of anesthesiology and resuscitation. An updated review and recommendations for our country Revista Espanola de Anestesiologia y Reanimacion 34(3): 196-205
Tsujimoto, S.; Kaminoh, Y.; Tashiro, C. 2005: The status of acquiring written informed consent to clinical practice of medical students in our department of anesthesiology Masui. Japanese Journal of Anesthesiology 54(7): 818-821
Wiesel, F.A. 1994: Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance British Journal of Psychiatry. Suppl 23: 65-70
Terlikowska, M.; Marzański, M. 1995: Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report Psychiatria Polska 29(3): 343-348
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148